Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies (Q80209074)
scientific article published on 01 September 2006
Language:
(P31) (Q13442814)
(P50) (Q64026418)
(Q66429840)
(P304) 5165-5173
(P433) 17
(P478) 12
(P577) Friday, September 1, 2006
(P921) (Q32089)
(P1433) (Q332253)
(P1476) "Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies" (language: en)
(P2093) Karen W L Yee
Zhihong Zeng
Marina Konopleva
Farhad Ravandi
Alessandra Ferrajoli
Deborah Thomas
William Wierda
Efrosyni Apostolidou
Susan O'Brien
Michael Andreeff
Francis J Giles
other details
description scientific article published on 01 September 2006

External Links